Automatically managing adapt-to-position and adapt-to-shape plans, ThinkQA Secondary Dose Check can swiftly verify, within a few minutes, the consistency of the TPS-calculated dose distribution with plan parameters. It confirms the plan's acceptability for each patient and each day.
With its user-friendly web platform and dashboard, the qualified professional users can visualize 3D dose distribution comparisons and key dosimetric indicators offered by ThinkQA Secondary Dose Check. These include whole matrix differential and cumulative DVH (Dose Volume Histograms) and Gamma Index Agreements (GAI) on automatic or target volumes. This enables the evaluation of potential dose calculation errors in the TPS plan.
Ad Statistics
Times Displayed: 49670
Times Visited: 1409 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Adding significant value to patient treatment safety within the U.S. adaptive radiotherapy market
FDA clearance paves the way for entry into the American market, enabling US clinics and hospitals to benefit from ThinkQA Secondary Dose Check - a valuable technological solution. This tool is designed with the flexibility to facilitate straightforward commissioning and seamless integration into diverse medical and IT environments.
Supporting multiple treatment techniques & energies (3D-CRT, IMRT, VMAT and FF & FFF beams) used in External Beam Radiation Therapy (EBRT) departments, ThinkQA Secondary Dose Check can be installed through a ready-to-use Elekta beam model template to ensure a perfect match with Elekta conventional Linacs for online and offline adaptive workflows.
Also customized for US clinics equipped with Elekta Unity MR-Linac, the solution is designed with careful consideration of the cryostat transmission and magnetic field effects on the dose. Utilizing gold standard beam model data for Elekta Unity, it provides a rapid secondary dose check outcome within the Elekta Unity planning workflow.
“Combining dose computation accuracy, relevant dose comparison metrics, and ergonomic web design, ThinkQA Secondary Dose Check simplifies and automates routine TPS plan verification.” concluded by Jean-Elie KAFROUNI, CEO in DOSIsoft Americas, “We are confident that ThinkQA Secondary Dose Check can meet the reporting and reimbursement needs of US Radiation Oncology departments, ensure compliance in plan quality, and instill confidence in patient safety by seamlessly integrating essential Patient QA.”
About ThinkQA
ThinkQA (Edition 2) Secondary Dose Check is CE marked as a class I medical device in Europe, under the new European Medical Device Regulation (EU) 2017/745. ThinkQA (Edition 2) is FDA 510(k) cleared as class II Medical Charged-Particle Radiation Therapy System. In line with other DOSIsoft Patient-QA solutions - EPIbeam for pretreatment verification and EPIgray for in vivo dosimetry - ThinkQA Secondary Dose Check is seamlessly integrated into the Elekta ONE Smart Workflows, exclusively distributed by Elekta.
